Stella Pharma Corporation

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

47

Website

www.stella-pharma.co.jp

Country

Japan

Exchange

Tokyo

Osaka, Japan

Stella Pharma provides the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its products include SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma, meningioma, and malignant melanoma and angiosarcoma. Incorporated in 2007, the company is headquartered in Osaka, Japan.

Key Stats

52-Week Range

¥200.00¥995.00

Beta0.28

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-22.94

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.